17-73338697-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144952.2(SDK2):c.6409C>A(p.Pro2137Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,455,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
SDK2
NM_001144952.2 missense
NM_001144952.2 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 7.73
Genes affected
SDK2 (HGNC:19308): (sidekick cell adhesion molecule 2) The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains two immunoglobulin domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. This protein, and a homologous mouse sequence, are very similar to the Drosophila sidekick gene product but the specific function of this superfamily member is not yet known. Evidence for alternative splicing at this gene locus has been observed but the full-length nature of additional variants has not yet been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3046022).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDK2 | NM_001144952.2 | c.6409C>A | p.Pro2137Thr | missense_variant | 45/45 | ENST00000392650.8 | NP_001138424.1 | |
SDK2 | XM_011524914.3 | c.6352C>A | p.Pro2118Thr | missense_variant | 44/44 | XP_011523216.1 | ||
SDK2 | XM_011524915.3 | c.6322+87C>A | intron_variant | XP_011523217.1 | ||||
SDK2 | XM_047436313.1 | c.6265+87C>A | intron_variant | XP_047292269.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDK2 | ENST00000392650.8 | c.6409C>A | p.Pro2137Thr | missense_variant | 45/45 | 5 | NM_001144952.2 | ENSP00000376421 | P1 | |
SDK2 | ENST00000424778.1 | c.3880C>A | p.Pro1294Thr | missense_variant | 27/27 | 5 | ENSP00000407098 | |||
SDK2 | ENST00000410094.5 | n.1482C>A | non_coding_transcript_exon_variant | 10/10 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000408 AC: 1AN: 245098Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132430
GnomAD3 exomes
AF:
AC:
1
AN:
245098
Hom.:
AF XY:
AC XY:
1
AN XY:
132430
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1455412Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 723540
GnomAD4 exome
AF:
AC:
1
AN:
1455412
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
723540
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.6409C>A (p.P2137T) alteration is located in exon 45 (coding exon 45) of the SDK2 gene. This alteration results from a C to A substitution at nucleotide position 6409, causing the proline (P) at amino acid position 2137 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
D;D
Sift4G
Benign
T;T
Polyphen
P;.
Vest4
MutPred
Gain of phosphorylation at P2137 (P = 0.0167);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at